Scientists at Trinity College Dublin have discovered that a part of the immune system called the inflammasome is involved in regulating the development of one of the most common forms of blindness, called Age-Related Macular Degeneration (AMD). They have discovered that controlling an inflammatory component IL-18, in cases of Age-Related Macular Degeneration (AMD) could prevent the development of …
Age-related macular degeneration
Study found possible association between drug and age-related macular degeneration
Daily aspirin use among seniors may double their risk of developing a particularly advanced form of age-related macular degeneration, a debilitating eye disease, a large new European study suggests. The possible link involves the so-called "wet" type of age-related macular degeneration (AMD), a significant cause of blindness in …
Magnetic stimulation as retinal treatment
Brainsway Ltd. has announced interim results from an animal study being conducted at the Sheba Medical Center to explore the effects of the company's transcranial magnetic stimulation device on age-related macular degeneration. A short-lasting improvement in the retina's response to light was observed following this stage of the study, with the rats who received the magnetic stimulation displaying …
Mayo Clinic work shows possible Lucentis side effect
At the Amercian Academy of Opthalmology 115th Annual Meeting, findings were presented from a retrospective study conducted after a Mayo Clinic opthalmologist noticed an increase in intraoccular pressure (IOP) in her patients using Genentech' (Roche) Lucentis (ranibizumab), an FDA-approved drug for the treatment of age-related macular degeneration (AMD). MARINA (Minimally Classic/OccultTrial of …